Page not found

Sorry, the page you requested is unavailable.
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr. Anil Adisesh at Dalhousie Medicine New Brunswick, Dalhousie University, and Dr. Trevor Dummer at the Centre of Excellence in Cancer Prevention, within the School of Population and Public Health at the University of British Columbia, will lead a team analyzing the world’s largest collection of toenails, all from Atlantic Canadians, to measure individual exposures to toxic metals that are known carcinogens and may cause prostate cancer. This research is part of a wider strategy by PCC to generate new and practical knowledge in the poorly understood area of prostate cancer prevention.  

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body. Now, Vancouver Prostate Centre (VPC) scientist Dr. Christopher Ong and colleagues have discovered a critical gene that drives cancer growth. From this discovery, they developed a new protein-based medication that prevents unhealthy cell growth that leads to prostate cancer, and potentially other cancers.   Dr. Ong shows support for Prostate Cancer Canada's annual Plaid for Dad fundraiser

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists. The course will be made available in both English and French. The anticipated start date of the course will be April 2018 and the course will be made available for one year after launch. 


news.listing.home